Tactile Medical Soars into 2026 with Record-Breaking First Quarter
Tactile Medical has kicked off the year on a high note, reporting a 23% year-over-year growth in revenue for its first quarter of 2026. The company's CEO, Sheri Dodd, credited this success to the execution of their strategic priorities and commercial action plan, which have yielded strong results across all business lines.
In terms of specific numbers, Tactile Medical's total revenue came out at $75.3 million for Q1 2026, with lymphedema revenue growing by 23% year-over-year to reach $62.2 million. Airway clearance revenue also saw a significant increase, rising by 22% year-over-year to $13 million.
The company's decision to acquire LymphaTech has begun to bear fruit, contributing a minimal amount to Q1 results but setting the stage for future growth. Tactile Medical's phase technology and people go-to-market investments are driving referrals and market share, while favorable advanced pump product mix and strong DME relationships continue to fuel their commercial momentum.
One of the key drivers behind this success is the company's operational execution across all business lines. Gross margins increased by a significant 250 basis points to reach 76.5%, and adjusted EBITDA saw a $4 million year-over-year increase to $3.7 million. This level of discipline and focus has enabled Tactile Medical to maintain substantial financial flexibility, ending the first quarter with approximately $75 million in cash.
As Tactile Medical looks ahead to 2026, they are updating their full-year revenue guidance to a range of $360 million-$368 million. This revised estimate takes into account the inclusion of LymphaTech and the company's increased confidence in commercial execution under new Medicare requirements for their category.
CEO Sheri Dodd highlighted the significant growth in lymphedema revenue, citing the momentum behind their field and back-office strategy execution. The company's go-to-market investments have delivered strong results, with territory productivity increasing meaningfully year-over-year. This success is also attributed to robust CRM utilization combined with enhancements such as workflow tools.
Tactile Medical's commitment to operational excellence has paid off, enabling the company to navigate recent changes in Medicare requirements and emerge even stronger. As they continue to invest in their people and technology, it will be exciting to see how this momentum translates into future quarters.
